Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2020 Oct;71(4):524–529. doi: 10.1097/MPG.0000000000002817

TABLE 4.

Frequency of feelings of isolation by treatment and age for respondents with eosinophilic esophagitis only

Age <18
Age ≥18
Never, infreq., or monthly, n (%) Weekly or daily, n (%) P Never, infreq., or monthly, n (%) Treatment type P
PPI
 No 15 (15.0) 11 (9.2) 0.19 23 (19.5) 15 (16.0) 0.51**
 Yes 85 (85.0) 108 (90.8) 95 (80.5) 79 (84.0)
Specific food elimination
 No 14 (12.4) 8 (6.5) 0.12 51 (40.5) 19 (19.4) <0.01
 Yes 99 (87.6) 116 (93.6) 75 (59.5) 79 (80.6)
Topical/swallowed steroids
 No 21 (21.2) 31 (26.3) 0.38 35 (30.2) 29 (31.5) 0.83
 Yes 78 (78.8) 87 (73.7) 81 (69.8) 63 (68.5)
Systemic steroids
 No 74 (82.2) 84 (73.7) 0.15 93 (86.1) 68 (80.0) 0.26
 Yes 16 (17.8) 30 (26.3) 15 (13.9) 17 (20.0)
Mast cell stabilizer agents
 No 57 (66.3) 68 (58.6) 0.27 77 (72.6) 56 (63.6) 0.18
 Yes 29 (33.7) 48 (41.4) 29 (27.4) 32 (36.4)
Immunomodulatory agents
 No 82 (98.8) 106 (94.6) 0.24* 95 (96.9) 79 (96.3) 0.82*
 Yes 1 (1.2) 6 (5.4) 3 (3.1) 3 (3.7)
Elemental diet
 No 88 (76.5) 81 (64.3) 0.04 123 (95.4) 87 (87.0) 0.02
 Yes 27 (23.5) 45 (35.7) 6 (4.7) 13 (13.0)
*

Fisher’s exact test.

**

Proton Pump Inhibitor.